Fig. 1

Subjects included in the study cohort. (1) Malignancy, stroke, severe hypertension, severe hypothyroidism, mobility impairment. (2) Patient participated in another drug study, 1 started interferon treatment, 6 dropouts, 12 excluded due to language difficulties. (3) 9 with cryptogenic cirrhosis, 21 alcoholic cirrhosis, 21 Non alcoholic fatty liver disease. (4) Subjects with previous decompensated liver disease